Goldstein alleged in her 2022 lawsuit that she became drowsy after taking an Equate-brand cough syrup containing the active ingredient dextromethorphan hydrobromide (DXM), despite the label ...

Robitussin owes some cold sufferers money as part of a class-action settlement. The cough medicine brand has agreed to pay $4.5 million to resolve claims that it duped consumers by marketing its ...

Buyers of Robitussin cough and cold syrup may be owed payment as part of a $4.5 million class action settlement over the drug’s “non-drowsy” labeling.

Buyers of Robitussin cough and cold syrup may be owed payment as part of a $4.5 million class action settlement over the drug’s “non-drowsy” labeling.

Buyers of Robitussin cough and cold syrup may be owed payment as part of a $4.5 million class action settlement over the drug’s “non-drowsy” labeling.

Buyers of Robitussin cough and cold syrup may be owed payment as part of a $4.5 million class action settlement over the drug’s “non-drowsy” labeling.

Buyers of Robitussin cough and cold syrup may be owed payment as part of a $4.5 million class action settlement over the drug’s “non-drowsy” labeling.

Buyers of Robitussin cough and cold syrup may be owed payment as part of a $4.5 million class action settlement over the drug’s “non-drowsy” labeling.

Buyers of Robitussin cough and cold syrup may be owed payment as part of a $4.5 million class action settlement over the drug’s “non-drowsy” labeling.

Buyers of Robitussin cough and cold syrup may be owed payment as part of a $4.5 million class action settlement over the drug’s “non-drowsy” labeling.

Buyers of Robitussin cough and cold syrup may be owed payment as part of a $4.5 million class action settlement over the drug’s “non-drowsy” labeling.